Patents by Inventor Gillian Langford

Gillian Langford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240181069
    Abstract: The present invention relates to a method of treating cancer in a subject.
    Type: Application
    Filed: November 7, 2023
    Publication date: June 6, 2024
    Inventors: Maria KOEHLER, Gillian LANGFORD, Stefan SYMEONIDES
  • Publication number: 20230165966
    Abstract: The present invention relates to a method of treating cancer in a subject.
    Type: Application
    Filed: July 11, 2022
    Publication date: June 1, 2023
    Inventors: Maria KOEHLER, Gillian Langford, Stefan Symeonides
  • Publication number: 20230025971
    Abstract: The present invention relates to a method of treating a cancer in a patient.
    Type: Application
    Filed: July 11, 2022
    Publication date: January 26, 2023
    Inventors: Gavin Bennett, Gillian Langford, Peter Park, Johanna Lahdenranta
  • Patent number: 11414488
    Abstract: The present invention relates to a method of treating a cancer in a patient.
    Type: Grant
    Filed: May 11, 2020
    Date of Patent: August 16, 2022
    Assignee: BICYCLERD LIMITED
    Inventors: Gavin Bennett, Gillian Langford, Peter Park, Johanna Lahdenranta
  • Publication number: 20200354456
    Abstract: The present invention relates to a method of treating a cancer in a patient.
    Type: Application
    Filed: May 11, 2020
    Publication date: November 12, 2020
    Inventors: Gavin BENNETT, Gillian LANGFORD, Peter PARK, Johanna LAHDENRANTA
  • Publication number: 20200129630
    Abstract: The present invention relates to a method of treating cancer in a subject.
    Type: Application
    Filed: October 30, 2019
    Publication date: April 30, 2020
    Inventors: Maria Koehler, Gillian Langford, Stefan Symeonides
  • Patent number: 7449562
    Abstract: The invention relates to porcine endogenous retrovirus (PERV) and novel methods of identification, isolation and screening via polynucleotide sequences. It also relates to use of said methods in providing a pig that does not express porcine endogenous retrovirus. The organs, tissues and cells of said pig being capable of use for xenotransplantaion.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: November 11, 2008
    Assignee: Novartis AG
    Inventors: Christopher Herring, Gillian Langford, Gary Quinn, Linda Scobie
  • Publication number: 20050066380
    Abstract: The invention relates to porcine endogenous retrovirus (PERV) and novel methods of identification, isolation and screening via polynucleotides sequences. It also relates to use of said methods in providing a pig that does not express porcine endogenous retrovirus. The organs, tissues and cells of said pig being capable of use for xenotransplantation.
    Type: Application
    Filed: June 28, 2002
    Publication date: March 24, 2005
    Inventors: Christopher Herring, Gillian Langford, Gary Quinn, Linda Scobie